EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study

Leo R Brown iD, Georgina G Thomson, Ellen Gardner, Siobhan Chien, Josh McGovern, Ross D Dolan, Stephen T McSorley, Matthew J Forshaw, Donald C McMillan, Stephen J Wigmore, Andrew B Crumley, Richard J E Skipworth iD

British Journal of Surgery · 03.04.2024 · 111 (4)

DOI: 10.1093/bjs/znae098 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Surgery, online erschienen am 09.04.2024. Verfasst von Leo R Brown und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal College of Surgeons (Edinburgh), NES, Chief Scientist's Office NASA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Features of cancer cachexia adversely influence patient outcomes, yet few currently inform clinical decision-making. This study assessed the value of the cachexia index (CXI), a novel prognostic marker, in patients for whom neoadjuvant chemotherapy and surgery for oesophagogastric cancer is planned.

Methods

Consecutive patients newly diagnosed with locally advanced (T3–4 or at least N1) oesophagogastric cancer between 1 January 2010 and 31 December 2015 were identified through the West of Scotland and South-East Scotland Cancer Networks. CXI was calculated as (L3 skeletal muscle index) × (serum albumin)/(neutrophil lymphocyte ratio). Sex-stratified cut-off values were determined based on the area under the curve (AUC), and patients were divided into groups with low or normal CXI. Primary outcomes were disease progression during neoadjuvant chemotherapy and overall survival (at least 5 years of follow-up).

Results

Overall, 385 patients (72% men, median age 66 years) were treated with neoadjuvant chemotherapy for oesophageal (274) or gastric (111) cancer across the study interval. Although patients with a low CXI (men: CXI below 52 (AUC 0.707); women: CXI below 41 (AUC 0.759)) were older with more co-morbidity, disease characteristics were comparable to those in patients with a normal CXI. Rates of disease progression during neoadjuvant chemotherapy, leading to inoperability, were higher in patients with a low CXI (28 versus 12%; adjusted OR 3.07, 95% c.i. 1.67 to 5.64; P < 0.001). Low CXI was associated with worsened postoperative mortality (P = 0.019) and decreased overall survival (median 14.9 versus 56.9 months; adjusted HR 1.85, 1.42 to 2.42; P < 0.001).

Conclusion

CXI is associated with disease progression, worse postoperative mortality, and overall survival, and could improve prognostication and decision-making in patients with locally advanced oesophagogastric cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsMaleHumansFemaleAgedCachexiaLymphocytesDisease ProgressionCohort StudiesPrognosisRetrospective Studies

Autor:innen und Institutionen

  • Clinical Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, UK.
  • Department of General Surgery, Forth Valley Royal Hospital, Larbert, UK.
  • Centre for Sustainable Delivery, Golden Jubilee Hospital, Glasgow, UK.
  • Academic Unit of Surgery, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.
  • Department of Upper Gastrointestinal Surgery, Glasgow Royal Infirmary, Glasgow, UK.

ORCID-Profile: Leo R Brown, Richard J E Skipworth

Förderung

  • Royal College of Surgeons (Edinburgh)
  • NES
  • Chief Scientist's Office NASA
  • NHS Research Scotland
  • CSO

Zitieren

APA

Brown, L. R., Thomson, G. G., Gardner, E., Chien, S., McGovern, J., Dolan, R. D., McSorley, S. T., Forshaw, M. J., McMillan, D. C., Wigmore, S. J., Crumley, A. B., & Skipworth, R. J. E. (2024). Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study. British Journal of Surgery, 111(4). https://doi.org/10.1093/bjs/znae098

Vancouver

Brown LR, Thomson GG, Gardner E, Chien S, McGovern J, Dolan RD, et al. Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study. British Journal of Surgery. 2024;111(4). doi:10.1093/bjs/znae098

BibTeX
@article{Brown2024,
  author = {Brown, Leo R and Thomson, Georgina G and Gardner, Ellen and Chien, Siobhan and McGovern, Josh and Dolan, Ross D and McSorley, Stephen T and Forshaw, Matthew J and McMillan, Donald C and Wigmore, Stephen J and Crumley, Andrew B and Skipworth, Richard J E},
  title = {Cachexia index for prognostication in surgical patients with locally advanced oesophageal or gastric cancer: multicentre cohort study},
  journal = {British Journal of Surgery},
  year = {2024},
  volume = {111},
  number = {4},
  doi = {10.1093/bjs/znae098}
}
Kostenlos starten →